SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-23-003349
Filing Date
2023-03-13
Accepted
2023-03-13 07:05:47
Documents
13
Period of Report
2023-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_031323.htm   iXBRL 8-K 27648
2 PRESS RELEASE ex99-01.htm EX-99.01 81023
  Complete submission text file 0001387131-23-003349.txt   298461

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE tnxp-20230313.xsd EX-101.SCH 3236
4 XBRL LABEL FILE tnxp-20230313_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE tnxp-20230313_pre.xml EX-101.PRE 22365
7 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8k_031323_htm.xml XML 3747
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 23725673
SIC: 2834 Pharmaceutical Preparations